Causalus Revenue and Competitors

The amount of medications increase substantially when patients have multiple conditions and illnesses. Polypharmacy is a well-known risk factor especially when it comes to problems related to the medication of the elderly. Long drug lists always require specialised medication reviews, which should also be revisited whenever medication or health conditions change. Pharmanalysis Oy is developing Causalus -software to solve the challenges related to polypharmacy. Causalus makes it easier and faster to review, monitor and standardise complex medications. As a result, harmful adverse effects of medication are minimized and the benefits maximized. This creates value for multiple parties: patient health and wellbeing is dramatically improved, which then saves resources from healthcare professionals and generates massive savings for healthcare service providers, municipalities and societies.